Intuitive Surgical Net Profit Margin 2010-2023 | ISRG
Current and historical net profit margin for Intuitive Surgical (ISRG) from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue. Intuitive Surgical net profit margin for the three months ending December 31, 2023 was .
| Intuitive Surgical Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-12-31 | $7.12B | $1.80B | 25.24% |
| 2023-09-30 | $6.85B | $1.52B | 22.14% |
| 2023-06-30 | $6.66B | $1.43B | 21.38% |
| 2023-03-31 | $6.43B | $1.31B | 20.40% |
| 2022-12-31 | $6.22B | $1.32B | 21.26% |
| 2022-09-30 | $6.12B | $1.38B | 22.54% |
| 2022-06-30 | $5.96B | $1.44B | 24.08% |
| 2022-03-31 | $5.91B | $1.65B | 27.85% |
| 2021-12-31 | $5.71B | $1.71B | 29.86% |
| 2021-09-30 | $5.49B | $1.69B | 30.78% |
| 2021-06-30 | $5.16B | $1.62B | 31.42% |
| 2021-03-31 | $4.55B | $1.17B | 25.77% |
| 2020-12-31 | $4.36B | $1.06B | 24.34% |
| 2020-09-30 | $4.31B | $1.05B | 24.47% |
| 2020-06-30 | $4.36B | $1.14B | 26.09% |
| 2020-03-31 | $4.61B | $1.39B | 30.12% |
| 2019-12-31 | $4.48B | $1.38B | 30.81% |
| 2019-09-30 | $4.25B | $1.32B | 30.96% |
| 2019-06-30 | $4.04B | $1.21B | 29.97% |
| 2019-03-31 | $3.85B | $1.15B | 29.81% |
| 2018-12-31 | $3.73B | $1.13B | 30.31% |
| 2018-09-30 | $3.57B | $0.80B | 22.52% |
| 2018-06-30 | $3.46B | $0.81B | 23.43% |
| 2018-03-31 | $3.31B | $0.78B | 23.53% |
| 2017-12-31 | $3.14B | $0.67B | 21.38% |
| 2017-09-30 | $3.01B | $0.91B | 30.24% |
| 2017-06-30 | $2.88B | $0.82B | 28.50% |
| 2017-03-31 | $2.79B | $0.78B | 28.04% |
| 2016-12-31 | $2.71B | $0.74B | 27.26% |
| 2016-09-30 | $2.63B | $0.72B | 27.50% |
| 2016-06-30 | $2.53B | $0.68B | 26.78% |
| 2016-03-31 | $2.45B | $0.63B | 25.65% |
| 2015-12-31 | $2.39B | $0.59B | 24.70% |
| 2015-09-30 | $2.31B | $0.55B | 23.61% |
| 2015-06-30 | $2.27B | $0.50B | 22.13% |
| 2015-03-31 | $2.20B | $0.47B | 21.46% |
| 2014-12-31 | $2.13B | $0.42B | 19.65% |
| 2014-09-30 | $2.10B | $0.44B | 20.83% |
| 2014-06-30 | $2.05B | $0.47B | 22.95% |
| 2014-03-31 | $2.12B | $0.53B | 24.82% |
| 2013-12-31 | $2.27B | $0.67B | 29.62% |
| 2013-09-30 | $2.30B | $0.68B | 29.59% |
| 2013-06-30 | $2.34B | $0.71B | 30.21% |
| 2013-03-31 | $2.30B | $0.70B | 30.59% |
| 2012-12-31 | $2.18B | $0.66B | 30.15% |
| 2012-09-30 | $2.07B | $0.63B | 30.62% |
| 2012-06-30 | $1.98B | $0.57B | 28.95% |
| 2012-03-31 | $1.87B | $0.53B | 28.63% |
| 2011-12-31 | $1.76B | $0.49B | 28.10% |
| 2011-09-30 | $1.65B | $0.46B | 28.12% |
| 2011-06-30 | $1.55B | $0.43B | 27.73% |
| 2011-03-31 | $1.47B | $0.40B | 27.24% |
| 2010-12-31 | $1.41B | $0.38B | 27.03% |
| 2010-09-30 | $1.35B | $0.34B | 25.17% |
| 2010-06-30 | $1.28B | $0.32B | 24.71% |
| 2010-03-31 | $1.19B | $0.29B | 24.31% |
| 2009-12-31 | $1.05B | $0.23B | 22.15% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $135.870B | $7.124B |
| Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.933B | 26.53 |
| DexCom (DXCM) | United States | $51.560B | 78.10 |
| Edwards Lifesciences (EW) | United States | $51.275B | 33.37 |
| IQVIA Holdings (IQV) | United States | $41.367B | 24.00 |
| Alcon (ALC) | Switzerland | $39.650B | 29.24 |
| IDEXX Laboratories (IDXX) | United States | $39.383B | 46.16 |
| STERIS (STE) | Ireland | $20.704B | 24.50 |
| Waters (WAT) | United States | $18.971B | 27.22 |
| Hologic (HOLX) | United States | $17.720B | 19.83 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.280B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.570B | 15.52 |
| ShockWave Medical (SWAV) | United States | $12.378B | 77.10 |
| Sysmex ADR (SSMXY) | Japan | $11.001B | 34.50 |
| Teleflex (TFX) | United States | $9.466B | 14.73 |
| Penumbra (PEN) | United States | $8.202B | 101.25 |
| Masimo (MASI) | United States | $7.302B | 40.95 |
| Globus Medical (GMED) | United States | $6.805B | 21.58 |
| Glaukos (GKOS) | United States | $5.289B | 0.00 |
| TransMedics (TMDX) | United States | $4.369B | 414.53 |
| Integer Holdings (ITGR) | United States | $3.743B | 22.62 |
| LivaNova (LIVN) | United Kingdom | $3.390B | 20.13 |
| PROCEPT BioRobotics (PRCT) | United States | $3.159B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.810B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.789B | 19.13 |
| Nihon Kohden (NHNKY) | Japan | $2.518B | 21.30 |
| Inari Medical (NARI) | United States | $2.433B | 0.00 |
| RxSight (RXST) | United States | $2.324B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.857B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.819B | 7.95 |
| Veracyte (VCYT) | United States | $1.599B | 0.00 |
| OPKO Health (OPK) | United States | $0.920B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.906B | 17.62 |
| Paragon 28 (FNA) | United States | $0.885B | 0.00 |
| Artivion (AORT) | United States | $0.868B | 84.28 |
| Silk Road Medical (SILK) | United States | $0.824B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.799B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.692B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.624B | 21.20 |
| SiBone (SIBN) | United States | $0.597B | 0.00 |
| IRadimed (IRMD) | United States | $0.552B | 30.92 |
| Pacific Biosciences Of California (PACB) | United States | $0.542B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.503B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.427B | 0.00 |
| Nevro (NVRO) | United States | $0.409B | 0.00 |
| NeuroPace (NPCE) | United States | $0.387B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.337B | 11.54 |
| Sight Sciences (SGHT) | United States | $0.288B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.248B | 0.00 |
| AxoGen (AXGN) | United States | $0.248B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.216B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.195B | 10.48 |
| 908 Devices (MASS) | United States | $0.194B | 0.00 |
| Accuray (ARAY) | United States | $0.178B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.161B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.160B | 0.00 |
| Neuronetics (STIM) | United States | $0.112B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.106B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.068B | 0.00 |
| Envoy Medical (COCH) | United States | $0.067B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.067B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.065B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.062B | 125.33 |
| Hyperfine (HYPR) | United States | $0.060B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.059B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.052B | 0.00 |
| InspireMD (NSPR) | Israel | $0.050B | 0.00 |
| DarioHealth (DRIO) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.041B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.039B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.037B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| PAVmed (PAVM) | United States | $0.021B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.020B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |